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Brief Report
Capillary leak leading to shock in Kawasaki disease without
myocardial dysfunction
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Abstract Kawasaki disease is an acute vasculitis of childhood. Its clinical presentation is well known, and
coronary artery aneurysms are classical complications. Shock and pleural or pericardiac effusion are rare
presentations of the disease. In intensive care units, the disease may be mistaken for septic shock or toxic shock
syndrome. Owing to the fact that immunoglobulin therapy improves the course of the disease, especially if
given early, and thus the diagnosis should not be delayed.
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K
AWASAKI DISEASE IS AN ACUTE, SYSTEMIC
vasculitis of unknown aetiology, which
mostly occurs in young children. In the
absence of specific tests, the diagnosis is based on
the presence of fever and at least four of the five
well-known clinical features. Incomplete Kawasaki
disease is defined by fever, two or three clinical
features, and coronary disease on echocardiography.
Approximately 15% to 25% of untreated children
develop coronary aneurysm. Owing to the fact that
intravenous immunoglobulin treatment reduces the
prevalence of coronary artery aneurysms to less than
5%,1 patients should rapidly be treated. Aspirin is
also part of the common treatment. Some patients
remain febrile despite the treatment and should be
treated again with intravenous immunoglobulin.2
Even though unusual, severe Kawasaki disease with
pleural and pericardial effusion or patients mimicking
toxic shock syndromes are possible but rare.3–5
Therefore, we report the cases of three children
admitted to our paediatric intensive care unit for
haemodynamic instability, respiratory failure, and
neurological impairment due to Kawasaki disease.
Case reports
Our institution is a tertiary centre in a region of
about one million inhabitants. In our paediatric
cardiology department, 15 to 20 cases of Kawasaki
disease are diagnosed per year. Of these, five to eight
are treated in our institution – small children,
severe disease, or particular risk factors.
The first child was a 5.5-year-old girl, presenting
first a classical Kawasaki disease. Cardiac echocar-
diography showed coronary hyperechogenicity and
dilatation, with significant z-scores for the common
truncus and the right coronary artery (Table 1).
Systolic function was normal, with an ejection
fraction of 63%, and the echocardiography did not
show any diastolic dysfunction. The girl was treated
with intravenous immunoglobulin and aspirin on
the fourth day of fever. Initially she improved for
3 days, but then she suddenly complained of
abdominal pain. Her general and neurological
state worsened. She was referred to the paediatric
intensive care unit. Initial work-up showed increased
C-reactive protein (241 milligrams per deciliter) and
white blood cell count of 12.83 109 per litre – 29%
of immature granulocytes – and decreased haemo-
globin of 90 grams per litre and serum albumin of
19 grams per litre. There was no sign of other
organ dysfunction, and troponin levels were slightly
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elevated (Table 2). Chest X-ray and abdominal
sonography revealed a large amount of ascites and
pleural effusion. Mechanical ventilation was initiated
for respiratory failure. After volume replacement with
colloid and albumin, we had to start catecholamines
because of persistent haemodynamic instability. A
second dose of intravenous immunoglobulin was
administered on the ninth day of fever – that is,
48 hours after admission to intensive care – and
aspirin was continued. Owing to this unusual
evolution mimicking septic shock, we also intro-
duced antibiotics after complete septic work-up.
Bacterial cultures were all negative. She gradually
improved over 5 days after the second intravenous
immunoglobulin dose. Catecholamines were stopped
after 7 days. She was discharged from the paediatric
intensive care unit after 8 days and from the hospital
after another 7 days. Control echocardiography
2 months later showed no coronary aneurysm.
The second child was a 6-year-old boy, presenting
with a cervical mass and fever, treated with
amoxicillin and clavulanic acid without any improve-
ment. He developed a rash after 4 days. After 7 days,
his clinical state worsened, with the apparition
of respiratory distress and rapidly progressive haemo-
dynamic instability. Initial work-up showed haemo-
globin (109 grams per litre), white blood cell count
of 33 109 per litre (57% of immature granulocytes),
C-reactive protein (220 grams per deciliter), and low
serum albumin (18 grams per litre). There was only
a slight elevation of liver enzymes and no sign of
organ failure (Table 2). He was admitted to the
intensive care with suspicion of either septic shock or
toxic shock syndrome. Chest X-ray and abdominal
sonography showed pleural and peritoneal effusion.
Mechanical ventilation was initiated because of
respiratory failure, and cardiovascular support with
volume replacement and cathecholamines because of
refractory hypotension. Antibiotic treatment was
changed to vancomycin, imipenem, and amikacin;
corticoid therapy was initiated because of capillary
leak and shock. Owing to the fact that the clinical
signs were indicative of Kawasaki disease – that is,
fever, cervical mass, and rash – an echocardiography
was performed the next day, showing coronary
aneurisms with a positive z-score (Table 1). Systolic
and diastolic functions were normal. The diagnosis
of incomplete Kawasaki disease was made, as other
causes were excluded and infectious work-up was
normal. Intravenous immunoglobulin and aspirin
treatment were started. The boy rapidly improved
within 24 hours. Catecholamines were stopped after
2 days, he could be extubated after 3 days, was
discharged from intensive care after 4 days and from
hospital after 3 weeks. The last available control
echocardiography, a few days after hospital stay,
showed no sign of coronary aneurysm.
The third child was a 3-year-old boy with a
prenatal history of Galien vein aneurism treated by
two successful embolisations in the first year of life.
He presented with a 1-week history of fever, sore
throat, and conjunctival injection. Oral amoxicillin
and clavulanic acid treatment was started; however,
the boy’s clinical state worsened, and therefore
he was admitted to the hospital for intravenous
antibiotic treatment. Laboratory studies showed signs
of important systemic inflammation, with an elevated
C-reactive protein (480 milligrams per deciliter),
Table 1. Echocardiographic values.
Anterior interventricular
coronary artery z-score
Commun coronary
truncus z-score
Right coronary
artery z-score
Ejection fraction
(%)
Patient 1 11.6 13.26 14.4 63
Patient 2 12.75 14.02 16.86 62
Patient 3 13.6 14.97 12.32 73
Table 2. Laboratory values at admission.
GOT
(IU/l)
GPT
(IU/l)
Creatinin
(mmol/l)
BUN
(mmol/l)
CRP
(mg/dl)
WBC
(g/l)
Immature
granulocytes
(%)
Hb
(g/l)
CK
(IU/l)
CK-MB
(IU/l)
Troponin
(mg/l)
Serum
albumin
(g/l)
Patient 1 54 44 78 8.3 468 12.8 29 90 231 47 0.09 19
Patient 2 46 44 57 8.7 164 3.5 57 83 140 12 0.74 18
Patient 3 31 79 32 14.1 372 21.4 39 75 21 30 0.03 26
BUN5 blood urea nitrogen; CK5 creatine kinase; CK-MB5 creatine kinase-muscle and brain types; CRP5 carbon-reactive protein;
GOT5 glutamic-oxaloacetic transaminase; GPT5 glutamic-pyruvic transaminase; Hb5 haemoglobin; WBC5white blood cell
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elevated white blood cell count (21.43 109 per
deciliter) with 39% of immature granulocytes. His
serum albumin was low (26 grams per litre). There
was no sign of organ dysfunction and troponin was
normal during the entire stay in the intensive care
unit (Table 2). The chest X-ray showed an enlarged
heart and the echocardiography showed pericardial
effusion. The boy was referred to the paediatric
intensive care unit. He progressively showed signs of
tamponade, thus making drainage necessary. Approxi-
mately 50 to 60 millilitres of exudate was removed,
and a drain was left in the pericardia. A biopsy was
also conducted, showing pericarditis. In spite of the
drainage, haemodynamic instability persisted and he
needed catecholamine. On echocardiography, coronary
aneurysms were described with positive z-scores
(Table 1), and systolic function was normal – with
an ejection fraction of 73% after drainage and 58%
before drainage – as was diastolic function. Coronary
aneurysms, in association with fever, sore throat,
and conjunctival injection, made the diagnosis of
Kawasaki disease very likely. Intravenous immuno-
globulin and aspirin treatment were introduced.
The course was complicated by a thrombus of the
superior caval vein, on the third day of the stay. He
was treated with alteplase (1 milligram per kilogram
over 3 hours), and subsequently he developed cerebral
haemorrhage with signs of intracranial hypertension.
Despite surgical and medical treatment, the child
died on day 7 after admission to intensive care.
Discussion
These three children presented haemodynamic
instability and respiratory failure due to Kawasaki
disease. They had severe vascular leakage and
hypoalbuminaemia, with pleural and pericardial
effusions and ascites. The shock was probably due
to an important inflammatory state and vascular
leakage, as none of them showed signs of cardiac
dysfunction on echocardiography.
Kawasaki disease is a systemic vasculitis; how-
ever, inflammatory lesions have been described in
other organs, including the heart, the lungs, the
haematopoietic and the nervous systems. This
inflammation leads to an exudative oedema and
increased vascular permeability.6 Terai et al worked
on the impact and physiopathology of inflammation
and vascular leakage in Kawasaki disease.7,8 The
increased vascular permeability in the acute phase
of Kawasaki disease is in relation with the elevation
of vascular endothelial growth factor expression.
Low serum albumin may be due to the increased
production of vascular endothelial growth factor
and consecutive increased vascular permeability.
Furthermore, they found a direct relation between the
severity of oedema and the development of coronary
aneurysms. They concluded that vascular leakage may
be a key feature of the physiopathology of Kawasaki
disease. Consequently, the vascular leakage and
inflammatory state could explain a great part of the
severity of the disease in our three children.
Owing to the fact that the diagnosis of this disease
is infrequent in the paediatric intensive care unit, and
that the way of presentation with shock may mimic
toxic shock syndrome or sepsis, there is a risk of
delayed diagnosis, and therefore delayed treatment. In
the report of eight patients admitted for toxic shock
syndrome, Wiesenthal and Todd9 described one
possible case of Kawasaki disease, revealed by coronary
aneurysms on control echocardiography. Dominguez
et al10 published the first English-written case-control
study of patients with Kawasaki disease presenting
with shock. They reviewed 14 paediatric intensive
care unit children with discharge diagnosis of
Kawasaki disease. The most common diagnosis at
admission was toxic shock syndrome or septic shock.
These children were mainly admitted to the paediatric
intensive care unit because of fluid-refractory hypo-
tension and the need for inotropic support, as did our
three patients. Interestingly, they found a significant
elevation in immature granulocytes and C-reactive
protein. Albumin was also significantly lower in the
children admitted to the paediatric intensive care unit
compared with their control population. We also
noticed these laboratory perturbation in our children,
which is a sign of important inflammatory state.
However, in contrast to their results, our children did
not present with renal failure, low platelet count, or
coagulopathy. High blood urea nitrogen values of our
children at admission were rapidly corrected with
fluid replacement; however, creatinine stayed within
the normal range and our children did not show any
other organ dysfunction.
Cardiac echocardiography of all three children
showed coronary artery dilatations. Troponin values
were normal to slightly elevated, showing some
myocardial inflammation; however, all three children
had good systolic and diastolic function, and there-
fore the shock was not due to myocardial dysfunction.
Conclusion
Although the diagnosis of Kawasaki disease is rare
in the paediatric intensive care unit, the disease can
mimic septic shock or toxic shock syndrome.
Therefore, clinicians should carefully look for clinical
signs of the disease and conduct an echocardio-
graphy whenever there is a doubt. Shock in
Kawasaki disease can be present even with normal
myocardial function, because of severe inflammation
and vascular leakage.
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